Results 151 to 160 of about 12,151 (255)

GLP‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels

open access: yesMicrocirculation, Volume 33, Issue 5, July 2026.
ABSTRACT Objectives Recent clinical studies have suggested that glucagon‐like peptide‐1 receptor (GLP‐1R) agonists may be effective therapies to treat or reduce the risk of developing secondary lymphedema. In this study, we aimed to (1) determine if GLP‐1Rs are present in the lymphatic vasculature and characterize their expression, and (2) assess the ...
Mary E. Schulz   +3 more
wiley   +1 more source

Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]

open access: yesFront Sports Act Living
Kojen AJ   +5 more
europepmc   +1 more source

Leukotriene antagonists attenuate late phase nitric oxide production during the hypersensitivity response in the conjunctiva

open access: yes, 2004
Objective: To investigate the role of cysteinyl leukotrienic (cysLT) antagonists on conjunctival nitric oxide (NO) release in experimental allergic conjunctivitis.
Papathanassiou, M.   +2 more
core  

Leukotriene-modifying agent chemoprophylaxis for severe influenza illness: a multi-approach study. [PDF]

open access: yesAm J Epidemiol
Snyder BM   +10 more
europepmc   +1 more source

Deacetylase inhibitors CM‐444 and CM‐1758 enhance chemotherapy response in AML via ALOX5

open access: yes
British Journal of Haematology, Volume 209, Issue 1, Page 329-334, July 2026.
Naroa Gimenez‐Camino   +7 more
wiley   +1 more source

Leukotriene antagonists and symptom control in chronic persistent asthma.

open access: yes, 2001
Ruth H Green   +3 more
core   +1 more source

The effect of lipoxygenase inhibitors and leukotriene antagonists on anaphylaxis

open access: yes, 1986
S. Franchi-Micheli   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy